
|Articles|February 8, 2004
Botox complications rare, but possible
As dermatologists accumulate knowledge about the injection of botulinumtoxin Type A, the safer the procedure is becoming, according to AlastairCarruthers, M.D.With reports of rare side effects, such as extreme fatigue and headaches,surfacing from sources across the United States, dermatologists might bequestioning the safety of a drug that continues to grow in popularity anddemand. But these concerns should be eased with sound evidence supportingthe contrary.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















